Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis

Fragile X syndrome (FXS) is the leading cause of inherited intellectual disability and autism spectrum disorder. Individuals with FXS often present with a wide range of cognitive deficits and problem behaviors. Educational, behavioral and pharmacological interventions are used to manage these and ot...

Full description

Bibliographic Details
Main Authors: Skylar Luu, Haley Province, Elizabeth Berry-Kravis, Randi Hagerman, David Hessl, Dhananjay Vaidya, Reymundo Lozano, Hilary Rosselot, Craig Erickson, Walter E. Kaufmann, Dejan B. Budimirovic
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Brain Sciences
Subjects:
fragile X syndrome
clinical trials placebo effect
meta-analysis
Online Access:https://www.mdpi.com/2076-3425/10/9/629

Internet

https://www.mdpi.com/2076-3425/10/9/629

Similar Items